Literature DB >> 9773390

In vivo evaluation of the absorption and gastrointestinal transit of avitriptan in fed and fasted subjects using gamma scintigraphy.

P H Marathe1, E P Sandefer, G E Kollia, D S Greene, R H Barbhaiya, R A Lipper, R C Page, W J Doll, U Y Ryo, G A Digenis.   

Abstract

The study was conducted to assess the bioavailability of avitriptan after a standard high fat meal, in relation to gastrointestinal transit. Six healthy male subjects were enrolled in a four-period study with a partial replicate design where each was administered 150-mg avitriptan capsule (i) after an overnight fast, (ii) 5 min after a standard high-fat breakfast, and (iii) 4 hr after a standard high fat breakfast. The treatment administered in Period 3 was repeated in Period 4 to assess intrasubject variations in pharmacokinetics and gastrointestinal (GI) transit. Avitriptan capsules were specially formulated with nonradioactive samarium chloride hexahydrate which was neutron-activated to gamma-emitting samarium before dosing. Serial blood samples were collected for analysis of avitriptan up to 24-hr postdose, and serial scintigraphic images were obtained to assess the plasma concentration-time profile in relation to the GI transit of the avitriptan capsule contents. Bioavailability of avitriptan was reduced when administered in the fed condition but only the decrease in AUC(INF) was statistically significant. Tmax was significantly delayed between the fed conditions and the fasted condition. Qualitative appearance of plasma concentration-time profiles for avitriptan could be related to the manner in which the drug emptied from the stomach. It was also apparent that avitriptan exerted a secondary pharmacologic effect that temporarily suspended gastric emptying in the fasted treatment. Thus, when gastric emptying was interrupted and then resumed, the net result was a double peak in some of the individual plasma concentration profiles. Scintigraphic analysis also demonstrated that upon emptying from the stomach, avitriptan was rapidly absorbed from the upper small intestine. In the fed state, gastric emptying was slow and continuous resulting in extended absorption and a lower occurrence of double peaks. Qualitatively, the intrasubject variability in Cmax and AUC could be explained by the intrasubject variability in gastric emptying in both fasted and fed conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773390     DOI: 10.1023/a:1023236823320

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  14 in total

1.  Disposition of [14C]avitriptan in rats and humans.

Authors:  P H Marathe; D S Greene; R H Barbhaiya
Journal:  Drug Metab Dispos       Date:  1997-07       Impact factor: 3.922

2.  Effect of sumatriptan, a new selective 5HT1-like agonist, on liquid gastric emptying in man.

Authors:  L A Houghton; P Fowler; O N Keene; N W Read
Journal:  Aliment Pharmacol Ther       Date:  1992-12       Impact factor: 8.171

Review 3.  Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.

Authors:  S S Davis; J G Hardy; S P Newman; I R Wilding
Journal:  Eur J Nucl Med       Date:  1992

Review 4.  Gamma scintigraphy and neutron activation techniques in the in vivo assessment of orally administered dosage forms.

Authors:  G A Digenis; E Sandefer
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1991       Impact factor: 4.889

5.  Assessment of effect of food, gender, and intra-subject variability in the pharmacokinetics of avitriptan.

Authors:  P H Marathe; D S Greene; J S Lee; R H Barbhaiya
Journal:  Biopharm Drug Dispos       Date:  1998-04       Impact factor: 1.627

6.  Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy.

Authors:  G A Digenis; E P Sandefer; A F Parr; R Beihn; C McClain; B M Scheinthal; I Ghebre-Sellassie; U Iyer; R U Nesbitt; E Randinitis
Journal:  J Clin Pharmacol       Date:  1990-07       Impact factor: 3.126

7.  The effect of meal composition on the gastrocolonic response: implications for drug delivery to the colon.

Authors:  J M Price; S S Davis; R A Sparrow; I R Wilding
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

8.  Radiolabeling of intact tablets by neutron activation for in vivo scintigraphic studies.

Authors:  A Parr; M Jay; G A Digenis; R M Beihn
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

9.  Gastrointestinal transit and release of mesalazine tablets in patients with inflammatory bowel disease.

Authors:  J N Healey
Journal:  Scand J Gastroenterol Suppl       Date:  1990

10.  Localization of drug release sites from an oral sustained-release formulation of 5-ASA (Pentasa) in the gastrointestinal tract using gamma scintigraphy.

Authors:  J G Hardy; W J Harvey; R A Sparrow; G B Marshall; K P Steed; M Macarios; I R Wilding
Journal:  J Clin Pharmacol       Date:  1993-08       Impact factor: 3.126

View more
  4 in total

Review 1.  Nonlinear dynamics and chaos theory: concepts and applications relevant to pharmacodynamics.

Authors:  A Dokoumetzidis; A Iliadis; P Macheras
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

Review 2.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

3.  Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptying.

Authors:  Kayode Ogungbenro; Henry Pertinez; Leon Aarons
Journal:  AAPS J       Date:  2014-11-21       Impact factor: 4.009

4.  Antimigraine Drug Avitriptan Is a Ligand and Agonist of Human Aryl Hydrocarbon Receptor That Induces CYP1A1 in Hepatic and Intestinal Cells.

Authors:  Barbora Vyhlídalová; Kristýna Krasulová; Petra Pečinková; Karolína Poulíková; Radim Vrzal; Zdeněk Andrysík; Aneesh Chandran; Sridhar Mani; Zdenek Dvorak
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.